Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK cancer data sharing initiative up for award:

This article was originally published in Clinica

Executive Summary

The UK's National Cancer Research Institute (NCRI) has been short-listed for a national award, based on its work in bringing together data gained in every area of cancer science and medicine into a single, full integrated and accessible knowledge base. The work, being put forward for a Times Higher Research Project of the Year 2005 award, aims to make cancer research data available and accessible and to streamline its translation into better prevention, treatment and care. Chairman of the NCRI, Professor Alex Markham, says: "Advances in scientific inquiry and modern technology are triggering the creation of huge amounts of new data, which is bursting out of the cancer research community in the UK." NCRI's initiative is vital in the understanding of how this information fits together, said Professor Markham.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT056940

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel